e-SPACE Cardio-Renal-Metabolic 2024

Published: 29 March 2024

  • Views:

    Views Icon 489

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) 2024.

 

A thoughtfully curated programme supported the exploration of how leading experts, in cardiology, nephrology and diabetology, treat the interrelated diseases.

 

This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Related sessions to e-SPACE Cardio-Renal-Metabolic 2024:

e-SPACE Cardio-Renal-Metabolic 2024 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • HF Specialists
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

6 sessions
Plenary Session 1 – Multidisciplinary implementation strategies Watch now
Keynote Session – KDIGO guideline updates 2024 Watch now
Plenary Session 2 – Guideline directed therapy for CRM disease: the evidence base Watch now
Plenary Session 3 – Managing the patients with CRM: who gets what, when and why? Watch now
Plenary Session 4 – Weight homeostasis management in CRM disease (Organised with support from Charité Friends & Sponsors Trust) Watch now
Plenary Session 5 – CRM disease: epidemiology and pathophysiology Watch now

Part 2

Day Two

6 sessions
Plenary Session 6 – Anaemia and iron deficiency Watch now
Practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk Watch now
Plenary Session 7 – Clinical presentations and treatment across the patient journey: focus on CKD and CVD Watch now
Plenary Session 8 – Early intervention and intensive management Watch now
Effects of GLP- 1RA on kidney outcomes in CKD and T2D Watch now
Plenary Session 9 – Precision medicine in CRM Watch now

Faculty Biographies

Vijay Chopra

Vijay Chopra

Senior Director of Clinical Cardiology, Heart Failure and Research

Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials. 

Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019. 

Dr Chopra has over 50 publications in peer-reviewed journals. 

Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted

View full profile
Deepak L Bhatt

Deepak L Bhatt

Executive Director of Interventional Cardiovascular Programs

Dr Deepak Bhatt is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School.

Dr Bhatt has more than 1,600 publications and has been listed by the Web of Science as a Highly Cited Researcher.

He is Editor of the peer-reviewed Journal of Invasive Cardiology and Editor-in-Chief of the Harvard Heart Letter for patients. He received the Eugene Braunwald Teaching Award for Excellence in the Teaching of Clinical Cardiology from Brigham and Women’s Hospital in 2017, ACC’s Distinguished Mentor Award in 2018, and AHA’s Distinguished Scientist Award in 2019.

View full profile
Michelle Wong

Michelle Wong

Clinical Assistant Professor

Dr Michelle Wong is a Clinical Assistant Professor, Division of Nephrology, at The University of British Columbia, Vancouver, CA.

 

View full profile
George L Bakris

George L Bakris

President Elect

Dr George L. Bakris, MD, is a distinguished member of the National Kidney Foundation's Board of Directors. As the Professor of Medicine and Director of the Comprehensive Hypertension Center at the University of Chicago Medicine, he brings a wealth of expertise to the forefront of medical education.

Previously serving as the Vice-Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago, Dr Bakris has made significant contributions to the understanding of hypertension, diabetic kidney disease, and nephropathy progression. With a prolific publication record boasting over 700 articles and book chapters, his work has significantly impacted the landscape of cardiovascular research.

Dr Bakris has played a pivotal role in shaping national guidelines, serving on committees such as the Joint National Committee (JNC) Writing Groups VI & 7, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.